Ovarian Cancer Drugs Market Research Reports

Ovarian Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (PARP, PD-L1 Inhibitors , Angiogenesis), By Major Markets (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Ovarian Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (PARP, PD-L1 Inhibitors , Angiogenesis), By Major Markets (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022

  • Report
  • 94 Pages
From
Drug Overview: Lynparza - Product Thumbnail Image

Drug Overview: Lynparza

  • Drug Pipelines
  • 61 Pages
From
Drug Overview: Rubraca - Product Thumbnail Image

Drug Overview: Rubraca

  • Drug Pipelines
  • 29 Pages
From
Drug analysis: Avastin - Product Thumbnail Image

Drug analysis: Avastin

  • Drug Pipelines
  • 116 Pages
From
Gene Therapy for Ovarian Cancer - A Pipeline Analysis Report - Product Thumbnail Image

Gene Therapy for Ovarian Cancer - A Pipeline Analysis Report

  • Report
  • 73 Pages
From
Ovarian Cancer: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Ovarian Cancer: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 239 Pages
From
Ovarian Cancer - Heat Map and Analysis - Product Thumbnail Image

Ovarian Cancer - Heat Map and Analysis

  • Drug Pipelines
  • 16 Pages
From
CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report - Product Thumbnail Image

CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report

  • Report
  • 2001 Pages
CAS 63717-27-1 Amifostine hydrate Chemical World Report - Product Thumbnail Image

CAS 63717-27-1 Amifostine hydrate Chemical World Report

  • Report
  • 2066 Pages
CAS 645-05-6 Altretamine Chemical World Report - Product Thumbnail Image

CAS 645-05-6 Altretamine Chemical World Report

  • Report
  • 2103 Pages
CAS 25316-40-9 Doxorubicin hydrochloride Chemical World Report - Product Thumbnail Image

CAS 25316-40-9 Doxorubicin hydrochloride Chemical World Report

  • Report
  • 2005 Pages
CAS 3223-07-2 Melphalan hydrochloride Chemical World Report - Product Thumbnail Image

CAS 3223-07-2 Melphalan hydrochloride Chemical World Report

  • Report
  • 2068 Pages
CAS 33419-42-0 Etoposide Chemical World Report - Product Thumbnail Image

CAS 33419-42-0 Etoposide Chemical World Report

  • Report
  • 2114 Pages
CAS 33069-62-4 Paclitaxel Chemical World Report - Product Thumbnail Image

CAS 33069-62-4 Paclitaxel Chemical World Report

  • Report
  • 2028 Pages
CAS 20537-88-6 Amifostine Chemical World Report - Product Thumbnail Image

CAS 20537-88-6 Amifostine Chemical World Report

  • Report
  • 2004 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
CAS 763113-22-0 (937799-91-2) Olaparib Chemical World Report - Product Thumbnail Image

CAS 763113-22-0 (937799-91-2) Olaparib Chemical World Report

  • Report
  • 2189 Pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • 2091 Pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • 2095 Pages
CAS Melphalan World Consumption Report - Product Thumbnail Image

CAS Melphalan World Consumption Report

  • Report
  • 2181 Pages
Loading Indicator

Far less common than breast cancer, but with a higher mortality rate, sufferers of ovarian cancer are experiencing significant unmet needs. There are therefore considerable market opportunities for drug designers and manufacturers in this life-saving sector of the pharmaceutical industry. In this section a host of cutting edge reports provide valuable insight into key markets such as China and the US, the latest drug development activities and the market trends (including sales, pricing and forecasts) for specific drugs like Doxil, Caelyx, Yondelis and Paclitaxel. You can also purchase reports that feature the latest strategies of major and niche industry players such as Alza Corporation, Amgen, Bristol-Myers Squibb, Cell Therapeutics, Genentech, GlaxoSmithKline, Immunogen, Ivax, OSI Pharmaceuticals and Raven Biotechnologies.
Show Less
Read more

adroll